ChemomAb Ltd.

CompanyIsrael

ChemomAb Ltd. develops one asset, in phase 2 (Nebokitug in nonalcoholic steatohepatitis). Mostly antibody acting on inflammation and CCL24; based in Israel.

Assets
1
Furthest
Phase 2
Trials
4
Signals
0

Pipeline

1

  • Nebokitug

    Monoclonal antibody neutralizing CCL24 to reduce inflammation and fibrosis

    Phase 2AntibodyInflammationCCL24nonalcoholic steatohepatitisprimary sclerosing cholangitis

Full company profiles: pipeline, trials, funding and people.

See Pro
  • Evidence behind the mechanisms1
  • Trials4
  • Similar companies6

Updated 7 Oct 2026 · 9 sources

Intelligence